Log in to save to my catalogue

Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodeg...

Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodeg...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2838249708

Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodegib

About this item

Full title

Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodegib

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ case reports, 2023-07, Vol.16 (7), p.e251273

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

The anti-PD-1 antibody cemiplimab has demonstrated effectiveness in the setting of locally advanced basal cell carcinoma (BCC) and squamous cell carcinoma. We describe a case of a large, locally invasive basosquamous carcinoma, an aggressive type of BCC, invading the left sternocleidomastoid muscle with near compression of the left internal jugular...

Alternative Titles

Full title

Complete response of a large basosquamous carcinoma following treatment with cemiplimab and vismodegib

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2838249708

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2838249708

Other Identifiers

ISSN

1757-790X

E-ISSN

1757-790X

DOI

10.1136/bcr-2022-251273

How to access this item